Melissa Smith

Biography
Dr. Smith obtained her PhD at Harvard University, and trained further at Insitut Pasteur, Paris and University of California, San Diego. Dr. Smith focuses on the development of disruptive technologies at the intersection of genomics, immunology, and virology. The primary goal of all of her work is to overcome prior technical limitations with innovative approaches that provide unparalleled resolution of the human immune system, enabling the development of effective and efficient precision therapeutic approaches.

---

Talk
Decoding immune diversity to deliver precision therapeutics
The Clairity platform delivers comprehensive personalized immune profiling enabling AIML-based modeling for targeted drug design, therapeutic response prediction, and autoimmunity risk assessment. We'll showcase key competitive differentiators, highlight multiple proven successes across diverse applications, and present our detailed roadmap toward companion diagnostics development, bridging immune diversity insights with precision medicine.

Genomic Profiling Showcase:
Clareo Biosciences, Inc.
Clareo Biosciences delivers the world's first comprehensive immune receptor profiling through the Clairty platform. Our complete immunogenomic intelligence enables companion diagnostics, predictive biomarkers, and precision drug design—accelerating therapeutic development, improving patient outcomes, and reducing adverse events across immunotherapy, vaccines, and autoimmunity.